Aristeia Capital’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Aristeia Capital’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-300,000	Closed	-$3.25M	–	279
2023 Q3	$3.25M	Hold	300,000	–	–	0.09%	56
2023 Q2	$3.19M	Sell	300,000 -1,070,312	-78%	-$11.3M	0.07%	91
2023 Q1	$14.3M	Buy	1,370,312 +869,911	+174%	+$9.01M	0.34%	77
2022 Q4	$5.13M	Buy	500,401 +268,145	+115%	+$2.72M	0.1%	213
2022 Q3	$2.33M	Buy	+232,256	New	+$2.32M	0.04%	366

Aristeia Capital's BIOS Position: Q4 2023 in Review

Aristeia Capital sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 300,000 shares — an estimated $3.25M sold.

Aristeia Capital first reported a position in BIOS in Q3 2022 and held it in 5 quarters. The position peaked at $14.3M in Q1 2023. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

Aristeia Capital reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Aristeia Capital sold 300,000 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $3.25M.
Aristeia Capital first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q3 2022 and held it in 5 quarters.
Aristeia Capital's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $14.3M in Q1 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Aristeia Capital's 13F filing for Q4 2023, filed 14 Feb 2024.